Copyright: ©Author(s) 2026.
World J Gastroenterol. Nov 28, 2026; 32(44): 120795
Published online Nov 28, 2026. doi: 10.3748/wjg.120795
Published online Nov 28, 2026. doi: 10.3748/wjg.120795
Table 4 Hazard ratios of overall survival by pathological stage
| Unadjusted | IPTW-adjusted | ||||
| HR (95%CI) | P value | HR (95%CI) | P value | ||
| pStage I | M-GC | 1.00 | 0.051 | 1.00 | 0.016 |
| EOGC | 0.31 (0.10-1.00) | 0.32 (0.10-1.03) | |||
| pStage II | M-GC | 1.00 | 0.095 | 1.00 | 0.225 |
| EOGC | 0.42 (1.48-1.16) | 0.55 (0.21-1.44) | |||
| pStage III | M-GC | 1.00 | 0.125 | 1.00 | 0.120 |
| EOGC | 0.62 (0.34-1.14) | 0.61 (0.32-1.14) | |||
| pStage IV | M-GC | 1.00 | 0.222 | 1.00 | 0.052 |
| EOGC | 0.60 (0.27-1.36) | 0.34 (0.11-1.01) | |||
| Total population | M-GC | 1.00 | 0.072 | 1.00 | 0.016 |
| EOGC | 0.69 (0.46-1.03) | 0.58 (0.37-0.90) | |||
- Citation: Jeong SA, Lee JB, Kim JH. Clinicopathological characteristics and survival outcomes of early-onset vs mid-aged gastric cancer using an evidence-based age cutoff. World J Gastroenterol 2026; 32(44): 120795
- URL: https://www.wjgnet.com/1007-9327/full/v32/i44/120795.htm
- DOI: https://dx.doi.org/10.3748/wjg.120795